Healthcare provider profile · identity verified

Rajneesh D Reddy, M.D.

Family Practice · FT. WORTH, TX · NPI 1285652586

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	783	289
Amlodipine Besylate	Amlodipine Besylate	316	123
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	299	89
Losartan Potassium	Losartan Potassium	287	104
Levothyroxine Sodium	Levothyroxine Sodium	283	106
Metformin Hcl	Metformin Hcl	277	96
Lisinopril	Lisinopril	268	106
Gabapentin	Gabapentin	232	88
Albuterol Sulfate Hfa	Albuterol Sulfate	229	84
Rosuvastatin Calcium	Rosuvastatin Calcium	211	83
Tamsulosin Hcl	Tamsulosin Hcl	193	73
Pantoprazole Sodium	Pantoprazole Sodium	177	79
Methylprednisolone	Methylprednisolone	175	127
Furosemide	Furosemide	174	73
Montelukast Sodium	Montelukast Sodium	172	69
Metoprolol Succinate	Metoprolol Succinate	166	63
Omeprazole	Omeprazole	166	58
Sertraline Hcl	Sertraline Hcl	157	64
Famotidine	Famotidine	155	77
Tizanidine Hcl	Tizanidine Hcl	152	63
Alendronate Sodium	Alendronate Sodium	148	51
Meloxicam	Meloxicam	143	49
Glipizide	Glipizide	130	53
Simvastatin	Simvastatin	130	49
Potassium Chloride	Potassium Chloride	116	42
Alprazolam	Alprazolam	105	24
Trazodone Hcl	Trazodone Hcl	103	38
Allopurinol	Allopurinol	102	36
Eliquis	Apixaban	95	30
Cefdinir	Cefdinir	94	69
Clopidogrel	Clopidogrel Bisulfate	94	34
Hydrochlorothiazide	Hydrochlorothiazide	87	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	30
Lovastatin	Lovastatin	80	26
Metoprolol Tartrate	Metoprolol Tartrate	80	33
Carvedilol	Carvedilol	75	29
Zolpidem Tartrate	Zolpidem Tartrate	74	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	19
Fluticasone Propionate	Fluticasone Propionate	67	30
Spironolactone	Spironolactone	67	24
Donepezil Hcl	Donepezil Hcl	66	27
Buspirone Hcl	Buspirone Hcl	65	20
Azithromycin	Azithromycin	64	54
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	21
Diazepam	Diazepam	57	15
Tramadol Hcl	Tramadol Hcl	55	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	21
Triamcinolone Acetonide	Triamcinolone Acetonide	51	33
Fenofibrate	Fenofibrate	46	16
Prednisone	Prednisone	46	21
Xarelto	Rivaroxaban	46	14
Lorazepam	Lorazepam	45	18
Azelastine Hcl	Azelastine Hcl	44	21
Janumet	Sitagliptin Phos/Metformin Hcl	42	11
Meclizine Hcl	Meclizine Hcl	42	23
Ropinirole Hcl	Ropinirole Hcl	42	16
Pregabalin	Pregabalin	41	15
Esomeprazole Magnesium	Esomeprazole Magnesium	40	16
Sucralfate	Sucralfate	39	22
Duloxetine Hcl	Duloxetine Hcl	37	17
Jardiance	Empagliflozin	36	12
Lactulose	Lactulose	36	23
Nebivolol Hcl	Nebivolol Hcl	36	13
Nystatin	Nystatin	36	19
Temazepam	Temazepam	36	suppressed
Atenolol	Atenolol	35	13
Cephalexin	Cephalexin	35	30
Glyxambi	Empagliflozin/Linagliptin	35	11
Januvia	Sitagliptin Phosphate	34	18
Myrbetriq	Mirabegron	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	12
Fluconazole	Fluconazole	31	22
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	12
Finasteride	Finasteride	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	21
Pioglitazone Hcl	Pioglitazone Hcl	28	13
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	27	16
Ozempic	Semaglutide	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Bupropion Xl	Bupropion Hcl	26	16
Hydralazine Hcl	Hydralazine Hcl	26	13
Oxybutynin Chloride	Oxybutynin Chloride	25	13
Nateglinide	Nateglinide	24	suppressed
Acarbose	Acarbose	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Folic Acid	Folic Acid	23	suppressed
Nitroglycerin	Nitroglycerin	23	15
Escitalopram Oxalate	Escitalopram Oxalate	22	11
Methotrexate	Methotrexate Sodium	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	17
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	11
Glimepiride	Glimepiride	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	11
Benazepril Hcl	Benazepril Hcl	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Methocarbamol	Methocarbamol	20	12
Solifenacin Succinate	Solifenacin Succinate	20	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Acetaminophen-Codeine	Acetaminophen With Codeine	18	14
Clonidine Hcl	Clonidine Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Linzess	Linaclotide	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Valsartan	Valsartan	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Estradiol	Estradiol	14	suppressed
Naproxen	Naproxen	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pentoxifylline	Pentoxifylline	14	suppressed
Fentanyl	Fentanyl	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error